Tadalafil/Oxytocin/PT-141 Nasal Spray

This compounded nasal spray combines tadalafil, oxytocin, and PT-141 in a 50mg/600IU/2.5mg per mL formulation. The product is positioned as a provider-reviewed sexual wellness option that brings together three distinct research pathways: PDE5 inhibition through tadalafil, intimacy and arousal signaling through oxytocin, and melanocortin receptor activity through PT-141. It should be evaluated as a prescription-only compounded medication, not as an over-the-counter supplement.

Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor that supports nitric-oxide mediated vasodilation. Oxytocin is a cyclic nonapeptide involved in pair bonding, social connection, and sexual response signaling. PT-141, also known as bremelanotide, is a melanocortin receptor agonist studied for centrally mediated sexual desire and arousal. The rationale for the combination is that sexual response can involve vascular, neurological, and relational signaling pathways rather than one isolated mechanism.

Because this is a compounded combination product, the exact fit depends on medical history, current medications, blood pressure status, cardiovascular risk, and provider judgment. Patients using nitrates, certain blood pressure medications, or other sexual-health therapies need clinician review before use. Payment or checkout does not guarantee fulfillment; all orders remain subject to eligibility review, prescription approval, and pharmacy availability.